Cencora, Inc. (COR)
Sector: Industrials
Industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries
Country: United States
Exchange: NYSE
Market cap: $59.13B
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Latest financial period: June 30, 2026
Filed with the SEC: August 5, 2026
Estimated earnings date: November 4, 2026
Profit #155 of 1483 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROIC | 28.0% | 24.5% | 32.1% | 60.0% |
Growth #546 of 1483 companies
Payout #483 of 1483 companies
Safety #1434 of 1483 companies
Price #447 of 1483 companies
